NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES

Serial Number 97296549
Registration 7064074
700

Registration Progress

Application Filed
Mar 4, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered
May 23, 2023

Trademark Image

NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES

Basic Information

Serial Number
97296549
Registration Number
7064074
Filing Date
March 4, 2022
Registration Date
May 23, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 23, 2023
Registration
Registered
Classes
042

Rights Holder

Angiex, Inc.

03
Address
150 CambridgePark Drive, 5th Floor
Cambridge, MA 02140

Ownership History

Angiex, Inc.

Original Applicant
03
Cambridge, MA

Angiex, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Chelsea E. Carbone

USPTO Deadlines

Next Deadline
1294 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-05-23)
Due Date
May 23, 2029
Grace Period Ends
November 23, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
May 23, 2023 NRCS E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 23, 2023 R.SR A REGISTERED-SUPPLEMENTAL REGISTER Loading...
Apr 21, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Apr 21, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 21, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 21, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 21, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 21, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 17, 2023 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Apr 12, 2023 ALIE A ASSIGNED TO LIE Loading...
Mar 31, 2023 AAUA E NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Loading...
Mar 30, 2023 IUAA P USE AMENDMENT ACCEPTED Loading...
Mar 30, 2023 CNTA O APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Loading...
Mar 7, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 7, 2023 IUAF S USE AMENDMENT FILED Loading...
Mar 7, 2023 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Mar 6, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 6, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 6, 2023 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Dec 22, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 22, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 22, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 15, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 9, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 8, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific research and development in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; research and product development services for others in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; Medical and scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease detection; Providing information on the subject of scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine
First Use Anywhere: Jan 10, 2020
First Use in Commerce: Jan 10, 2020

Classification

International Classes
042